3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
702
Other hematologic neoplasm
249
Plasma cell
17
Myeloid
14
Sarcoma
10
Dermatologic
6
Classical hematology
4
CNS
4
Thoracic
3
Head & Neck
3
Genitourinary
2
Gastrointestinal
2
Breast
2
Tumor-Agnostic
1
Other
1
Gynecologic
1
Conditions
Mucositis
1
Leukemia
1
Interventions
Exercise
15
Metformin
14
Surveys and Questionnaires
12
Radiotherapy
9
Methods
7
naloxegol
6
Nutrition Assessment
6
Counseling
6
alvimopan
5
Resistance Training
5
Psychiatric Rehabilitation
5
Exenatide
5
Early Intervention, Educational
5
Diet Therapy
5
Diet
5
Sugars
4
Mindfulness-Based Stress Reduction
4
Injections
4
Fibroblast Growth Factor 7
4
Educational Status
4
Drug Therapy
4
Vitamin D
3
Therapeutics
3
Standard of Care
3
Liraglutide
3
Interviews as Topic
3
Fentanyl
3
Cryotherapy
3
Cognitive Behavioral Therapy
3
Cisplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Rituximab
×
Other
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed